Search details
1.
Fully human glyco-optimized recombinant FSH (follitropin epsilon) - a randomized, comparator-controlled phase II clinical trial.
Reprod Biomed Online
; 40(2): 331-341, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31982355
2.
A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
Hum Reprod
; 32(8): 1639-1647, 2017 08 01.
Article
in English
| MEDLINE | ID: mdl-28591833
3.
Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours.
ESMO Open
; 3(4): e000381, 2018.
Article
in English
| MEDLINE | ID: mdl-30018811
4.
Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas.
ESMO Open
; 3(2): e000303, 2018.
Article
in English
| MEDLINE | ID: mdl-29464112
5.
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.
J Clin Endocrinol Metab
; 91(11): 4612-9, 2006 Nov.
Article
in English
| MEDLINE | ID: mdl-16912128
Results
1 -
5
de 5
1
Next >
>>